- CA$109.70m
- CA$220.38m
- $97.44m
- 47
- 62
- 24
- 40
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.82 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -13.02% | ||
| Return on Equity | n/a | ||
| Operating Margin | -21.37% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 19.03 | 57.63 | 104.57 | 107.66 | 97.44 | 119.59 | n/a | 91.68% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
4Front Ventures Corp. is a multi-state cannabis operator and retailer. The Company owns or manages licensed cannabis facilities in state-licensed markets in the United States. It manufactures and distributes a portfolio of over 25 cannabis brands including Marmas, Crystal Clear, Island, Verdure, and the Pure Ratios wellness collection, which is distributed through retail outlets, as well as the Company’s chain of branded dispensaries. The Company's segments include THC Cannabis and CBD Wellness. The THC Cannabis segment is engaged in cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third-party retailers, ancillary services supporting wholesale operations, and retail sales direct to end consumers. It also leases real estate and sells equipment, supplies, and intellectual property to cannabis producers in the state of Washington. The Company’s CBD Wellness segment sells non-THC hemp derived products across the United States.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 31st, 2019
- Public Since
- December 5th, 2006
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Canadian Securities Exchange- Shares in Issue
- 914,200,201
- Address
- 7010 E Chauncey Lane #235, PHOENIX, 85054
- Web
- https://4frontventures.com/
- Phone
- +1 6026333067
- Auditors
- Davidson & Company LLP
Upcoming Events for FFNT
4Front Ventures Corp Annual Shareholders Meeting
Q2 2024 4Front Ventures Corp Earnings Release
Similar to FFNT
Ascend Wellness Holdings
Canadian Securities Exchange
Atlas Global Brands
Canadian Securities Exchange
Ayr Wellness
Canadian Securities Exchange
Braxia Scientific
Canadian Securities Exchange
Cansortium
Canadian Securities Exchange
FAQ
What is the 4Front Ventures share price?
As of Today at 19:00 UTC, shares in 4Front Ventures are trading at CA$0.12. This share price information is delayed by 15 minutes.
How has the 4Front Ventures share price performed this year?
Shares in 4Front Ventures last closed at CA$0.12 and the price had moved by -52% over the past 365 days. In terms of relative price strength the 4Front Ventures share price has underperformed the Toronto Stock Exchange 300 Composite Index by -55.07% over the past year.
What are the analyst and broker recommendations for 4Front Ventures?
The overall consensus recommendation for 4Front Ventures is Sell. You can view the full broker recommendation list by unlocking its StockReport.
What is the 4Front Ventures dividend yield?
4Front Ventures does not currently pay a dividend.
Does 4Front Ventures pay a dividend?
4Front Ventures does not currently pay a dividend.
When does 4Front Ventures next pay dividends?
4Front Ventures does not currently pay a dividend.
How do I buy 4Front Ventures shares?
To buy shares in 4Front Ventures you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of 4Front Ventures?
As of the previous close price of CA$0.12, shares in 4Front Ventures had a market capitalisation of CA$109.70m.
Where are 4Front Ventures shares listed?
Here are the trading details for 4Front Ventures:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: FFNT
What kind of share is 4Front Ventures?
Based on an overall assessment of its quality, value and momentum 4Front Ventures is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a 4Front Ventures share price forecast for 2024?
The analyst consensus target price for shares in 4Front Ventures is CA$0.15. That is 25.32% above the last closing price of CA$0.12.
Analysts covering 4Front Ventures currently have a consensus Earnings Per Share (EPS) forecast of -$0.05 for the next financial year.
What is the trend in the 4Front Ventures share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 4Front Ventures. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -54.06%.
As of the last closing price of CA$0.12, shares in 4Front Ventures were trading -36.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the 4Front Ventures PE Ratio?
The 4Front Ventures PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of 4Front Ventures?
We do not have data on 4Front Ventures' directors